Vimarsana
Biggest News Aggregation in the World

Virtual Life Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Virtual Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Virtual Life Sciences Today - Breaking & Trending Today

Investegate |Galapagos NV Announcements | Galapagos NV: Galapagos to present at upcoming investor conferences - Vimarsana News

Investegate |Galapagos NV Announcements | Galapagos NV: Galapagos to present at upcoming investor conferences

Investegate announcements from Galapagos NV, Galapagos to present at upcoming investor conferences

Sensorion to Attend Two Conferences in June 2021 - Vimarsana News

Sensorion to Attend Two Conferences in June 2021

Regulatory News: Sensorion (FR0012596468 ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the

SynAct Pharma: Interim report January-March 2021 - Vimarsana News

SynAct Pharma: Interim report January-March 2021

The Group's profit before tax amounted to -14,070 ( -3,822) TSEK. The Group's earnings per share amounted to -0.46 (-0.14). The average number of shares for the period was 25,366,295. "SynAct Pharma AB" means the parent company SynAct Pharma AB with corporate registration number 559058-4826. The "Company" or "SynAct" means the Group, i.e. SynAct Pharma AB and its wholly owned subsidiary SynAct Pharma ApS. definitions Earnings per share: Profit for the period divided by the average number of shares outstanding in the period. Equity/assets ratio: Equity divided by total capital. Significant ev...

Source: realtid.se